what is retatrutide used for Retatrutide: 24% Weight Loss Without Dieting? The Retatrutide Dosage Chart

Not everyone taking a GLP-1 medicine will experience the same benefits

Retatrutide is a triple-agonist, meaning it targets three different receptors: the GLP-1 (glucagon-like peptide-1) receptor, the GIP (glucose-dependent insulinotropic polypeptide) receptor, and the GCG (glucagon) receptor.

Tirzepatide, also known by its brand name Mounjaro, is a dual-acting peptide that targets two key receptors involved in appetite suppression and insulin sensitivity

Gastroparesis (stomach paralysis), which has been linked to Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, and Trulicity, causes constant and severe nausea and vomiting, abdominal pain, severe dehydration, acid reflux, malnutrition, and weight loss

Retatrutide is an experimental metabolic therapy designed to treat obesity and related metabolic disorders